Validating core scientific hypotheses and early digital health models. Supported by foundational programs, startups gain access to shared wet labs, data collaboration platforms, and early-stage capital connections to build strong proof-of-concept models.

Translating lab discoveries and digital solutions toward clinical applications. Innovators benefit from bio-analytics infrastructure, the HKSTP HA Data Collaboration Lab for healthtech, and Series A venture support to prepare candidates and software for trials.

Advancing therapeutics, medtech, and digital health platforms through active clinical trials and real-world validation. HKSTP connects companies with regional clinical trial networks, medical institutions, and expansion capital to navigate strict regulatory approvals.

Bridging R&D and pilot-scale production. Utilizing state-of-the-art Innofacturing facilities, startups can manufacture high-value biomedical products, wearables, and medical devices in Hong Kong under international GMP standards.

Bringing approved therapies, medtech devices, and digital health tech directly to healthcare providers and patients. We facilitate local and global market entry through strategic corporate, hospital, and clinical partnerships and oversea exibition delegation.

Capitalizing on Hong Kong's position as a premier global fundraising hub for both biotech and healthtech. HKSTP provides pre-IPO advisory and ecosystem support to help mature companies achieve global market leadership.